Valenteković S, Keglevíc D
Carbohydr Res. 1980 Jun;82(1):31-43. doi: 10.1016/s0008-6215(00)85517-2.
The 2,3,4,6-tetra-O-benzyl-1-O-(N-benzyloxycarbonyltripeptidyl)-D-glucopyranoses ), 8, and 13 were synthesised from 2,3,4,6-tetra-O-benzyl-alpha-D-glucopyranose and the active esters of the appropriate N-protected tripeptides (Gly-Cly-Gly-, L-Phe-Gly-Gly-, and Gly-Gly-L-Phe-) in the presence of imidazole; the anomeric mixtures were resolved and the alpha and beta anomers characterised. The beta anomer of 13, containing the L and D enantiomers (ratio approximately 3:1) of Gly-Gly-Phe- as the aglycon, could be resolved by column chromatography into the pure isomeric forms. Catalytic hydrogenolysis of the beta anomers, in the presence and absence of a strong acid, yielded the free 1-esters 2 beta, 9 beta, and 14 beta, which were characterised as the monoxalate or trifluoroacetate salts and as free bases. Similarly, the alpha anomers afforded 2 alpha, 9 alpha, and 14 alpha, whereas omission of the strong acid led to accompanying 1 leads to 2 acyl migration, to give the 2-O-acyl derivatives. All of the compounds prepared were converted into the N-acetyl and/or peracetylated derivatives. The 1-esters 2 beta and 9 beta, both in the charged and uncharged form, and the trifluoroacetate salt of 14 beta, are susceptible to cleavage by beta-D-glucosidase; the enzyme had no effect on the uncharged form of 14 beta. This difference between 14 beta and its salt is discussed in conformational terms.
2,3,4,6-四-O-苄基-1-O-(N-苄氧羰基三肽基)-D-吡喃葡萄糖(化合物2、8和13)由2,3,4,6-四-O-苄基-α-D-吡喃葡萄糖与相应的N-保护三肽(甘氨酰-甘氨酰-甘氨酸、L-苯丙氨酰-甘氨酰-甘氨酸和甘氨酰-甘氨酰-L-苯丙氨酸)的活性酯在咪唑存在下合成;对异头物混合物进行拆分,并对α和β异头物进行表征。化合物13的β异头物,其苷元为甘氨酰-甘氨酰-苯丙氨酸的L和D对映体(比例约为3:1),可通过柱色谱拆分为纯的异构体形式。在有和没有强酸存在的情况下,对β异头物进行催化氢解,得到游离的1-酯2β、9β和14β,它们被表征为单草酸酯或三氟乙酸盐以及游离碱。类似地,α异头物得到2α、9α和14α,而省略强酸会导致伴随1导致2的酰基迁移,得到2-O-酰基衍生物。所有制备的化合物都被转化为N-乙酰基和/或全乙酰化衍生物。1-酯2β和9β,无论是带电荷形式还是不带电荷形式,以及14β的三氟乙酸盐,都易被β-D-葡萄糖苷酶裂解;该酶对14β的不带电荷形式没有作用。从构象角度讨论了14β与其盐之间的这种差异。